RECRUITINGOBSERVATIONAL
Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
About This Trial
The investigators' primary objective is to assess whether a difference in the occurrence of bleeding events exist between patients with LVT treated with DOACs as compared to those treated with VKAs.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients at least 18 years old at enrolment
- With a LVT identified at echocardiography, MRI or CT between January 1st, 2013 and July 31st, 2020
- Treated at least once at the Inselspital or in another site of the Insel Gruppe
- Able to provide a written willing to sign a consent form
Who Should NOT Join This Trial:
- Documented refusal
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients at least 18 years old at enrolment
* With a LVT identified at echocardiography, MRI or CT between January 1st, 2013 and July 31st, 2020
* Treated at least once at the Inselspital or in another site of the Insel Gruppe
* Able to provide a written informed consent
Exclusion Criteria:
* Documented refusal
Locations (1)
Department of Cardiology, University Hospital Bern
Bern, Switzerland